tiprankstipranks
Fresenius SE & Co (FSNUY)
OTHER OTC:FSNUY

Fresenius SE & Co (FSNUY) Stock Price & Analysis

83 Followers

FSNUY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.40 - $8.34
Previous Close$7.52
Volume35.42K
Average Volume (3M)47.02K
Market Cap
$16.79B
Enterprise Value$56.67B
Total Cash (Recent Filing)€2.35B
Total Debt (Recent Filing)€27.76B
Price to Earnings (P/E)N/A
Beta0.53
May 08, 2024
Next Dividend Ex-DateN/A
Dividend Yield2.23%
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,252,949,108
10 Day Avg. Volume58,573
30 Day Avg. Volume47,023
Standard Deviation0.10
R-Squared0.32
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-1.13
Price to Sales (P/S)0.56
Price to Cash Flow (P/CF)2.40
P/FCF Ratio4.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%<0.01%100.00%
0.00%
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

FSNUY FAQ

What was Fresenius SE & Co’s price range in the past 12 months?
Fresenius SE & Co lowest stock price was $6.40 and its highest was $8.34 in the past 12 months.
    What is Fresenius SE & Co’s market cap?
    Currently, no data Available
    When is Fresenius SE & Co’s upcoming earnings report date?
    Fresenius SE & Co’s upcoming earnings report date is May 08, 2024 which is tomorrow.
      How were Fresenius SE & Co’s earnings last quarter?
      Fresenius SE & Co released its earnings results on Feb 21, 2024. The company reported $0.189 earnings per share for the quarter, missing the consensus estimate of $0.2 by -$0.011.
        Is Fresenius SE & Co overvalued?
        According to Wall Street analysts Fresenius SE & Co’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Fresenius SE & Co pay dividends?
          Fresenius SE & Co does not currently pay dividends.
          What is Fresenius SE & Co’s EPS estimate?
          Fresenius SE & Co’s EPS estimate is $0.19.
            How many shares outstanding does Fresenius SE & Co have?
            Fresenius SE & Co has 2,252,949,200 shares outstanding.
              What happened to Fresenius SE & Co’s price movement after its last earnings report?
              Fresenius SE & Co reported an EPS of $0.189 in its last earnings report, missing expectations of $0.2. Following the earnings report the stock price went up 0.426%.
                Which hedge fund is a major shareholder of Fresenius SE & Co?
                Currently, no hedge funds are holding shares in FSNUY
                ---

                Fresenius SE & Co Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                7.87%
                12-Months-Change

                Fundamentals

                Return on Equity
                2.15%
                Trailing 12-Months
                Asset Growth
                -38.66%
                Trailing 12-Months

                Company Description

                Fresenius SE & Co

                Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises dialysis products and healthcare services. The Fresenius Kabi segment specializes intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.
                ---

                FSNUY Company Deck

                ---

                FSNUY Earnings Call

                Q4 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                AbbVie
                Bristol-Myers Squibb
                Amgen
                Johnson & Johnson
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis